Clinical Medicine


  Listando 61 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   2   Wikipedia   45   News   4   Policy
Article Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC Socinski, M. A.; Jotte, R. M.; Cappuzzo, F.; Orlandi, F.; Stroyakovskiy, D.; Nogami, N.; Rodriguez-Abreu, D.; Moro-Sibilot, D.; Thomas, C. A.; Barlesi, F.; Finley, G.; Kelsch, C.; Lee, A.; Coleman, S.; Deng, Y.; Shen, Y.; Kowanetz, M.; Lopez-Chavez, A.; Sa NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2018) DOI / 10.1056/nejmoa1716948
Mentions   0   Wikipedia   17   News   0   Policy
Article Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial Provencio, Mariano; Nadal, Ernest; Insa, Amelia; Rosario Garcia-Campelo, Maria; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lopez Vivanco, Guillermo; del Ba LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(20)30453-8
Mentions   0   Wikipedia   23   News   1   Policy
Article Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC Ramalingam, S. S.; Vansteenkiste, J.; Planchard, D.; Cho, B. C.; Gray, J. E.; Ohe, Y.; Zhou, C.; Reungwetwattana, T.; Cheng, Y.; Chewaskulyong, B.; Shah, R.; Cobo, M.; Lee, K. H.; Cheema, P.; Tiseo, M.; John, T.; Lin, M-C; Imamura, F.; Kurata, T.; Todd, A. NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2020) DOI / 10.1056/nejmoa1913662 Bronze
Mentions   0   Wikipedia   28   News   0   Policy
Article Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial Nakagawa, Kazuhiko; Garon, Edward B.; Seto, Takashi; Nishio, Makoto; Aix, Santiago Ponce; Paz-Ares, Luis; Chiu, Chao-Hua; Park, Keunchil; Novello, Silvia; Nadal, Ernest; Imamura, Fumio; Yoh, Kiyotaka; Shih, Jin-Yuan; Au, Kwok Hung; Moro-Sibilot, Denis; Ena LANCET ONCOLOGY 1470-2045 (2019) DOI / 10.1016/s1470-2045(19)30634-5
Mentions   0   Wikipedia   5   News   0   Policy
Article Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours Fernandes Neto, Joao M.; Nadal, Ernest; Bosdriesz, Evert; Ooft, Salo N.; Farre, Lourdes; McLean, Chelsea; Klarenbeek, Sjoerd; Jurgens, Anouk; Hagen, Hannes; Wang, Liqin; Felip, Enriqueta; Martinez-Marti, Alex; Vidal, August; Voest, Emile; Wessels, Lodewyk NATURE COMMUNICATIONS (2020) DOI / 10.1038/s41467-020-16952-9 Green submitted, Green published, Gold
Mentions   0   Wikipedia   10   News   0   Policy
Review KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target Roman, Marta; Baraibar, Iosune; Lopez, Ines; Nadal, Ernest; Rolfo, Christian; Vicent, Silvestre; Gil-Bazo, Ignacio MOLECULAR CANCER (2018) DOI / 10.1186/s12943-018-0789-x Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article SHP2 is required for growth of KRAS-mutant non-small-cell lung cancer in vivo Mainardi, Sara; Mulero-Sanchez, Antonio; Prahallad, Anirudh; Germano, Giovanni; Bosma, Astrid; Krimpenfort, Paul; Lieftink, Cor; Steinberg, Jeffrey D.; de Wit, Niels; Goncalves-Ribeiro, Samuel; Nadal, Ernest; Bardelli, Alberto; Villanueva, Alberto; Bernard NATURE MEDICINE 1078-8956 (2018) DOI / 10.1038/s41591-018-0023-9
Mentions   0   Wikipedia   1   News   0   Policy
Article Epigenetic prediction of response to anti-PD-1 treatment in non-small-cell lung cancer: a multicentre, retrospective analysis Duruisseaux, Michael; Martinez-Cardus, Anna; Calleja-Cervantes, Maria E.; Moran, Sebastian; Castro de Moura, Manuel; Davalos, Veronica; Pineyro, David; Sanchez-Cespedes, Montse; Girard, Nicolas; Brevet, Marie; Giroux-Leprieur, Etienne; Dumenil, Coraline; P LANCET RESPIRATORY MEDICINE 2213-2600 (2018) DOI / 10.1016/s2213-2600(18)30284-4 Green accepted
Mentions   0   Wikipedia   1   News   0   Policy
Article Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy Casarrubios, Marta; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia Campelo, Maria del Rosario; Lazaro, Martin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; de Castro-Carpeno, Javier; Cobo, Manuel; Lopez-Viva CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-1200
Mentions   0   Wikipedia   0   News   0   Policy
Review On target: Rational approaches to KRAS inhibition for treatment of non-small cell lung carcinoma Lindsay, Colin R.; Garassino, Marina C.; Nadal, Ernest; Ohrling, Katarina; Scheffler, Matthias; Mazieres, Julien LUNG CANCER 0169-5002 (2021) DOI / 10.1016/j.lungcan.2021.07.005 Green published, Hybrid
Mentions   0   Wikipedia   3   News   0   Policy
Article Lung cancer patients with COVID-19 in Spain: GRAVID study Provencio, Mariano; Mazarico Gallego, Jose Maria; Calles, Antonio; Antonanzas, Monica; Pangua, Cristina; Mielgo Rubio, Xabier; Nadal, Ernest; Lopez Castro, Rafael; Lopez-Martin, Ana; del Barco, Edel; Domine, Manuel; Franco, Fernando; Diz, Pilar; Sandoval, LUNG CANCER 0169-5002 (2021) DOI / 10.1016/j.lungcan.2021.05.014 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial Laza-Briviesca, Raquel; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia-Campelo, Maria del Rosario; Huidobro, Gerardo; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lop CLINICAL AND TRANSLATIONAL MEDICINE 2001-1326 (2021) DOI / 10.1002/ctm2.491 Green published, Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020) Nadal, E.; Bosch-Barrera, J.; Cedres, S.; Coves, J.; Garcia-Campelo, R.; Guirado, M.; Lopez-Castro, R.; Ortega, A. L.; Vicente, D.; de Castro-Carpeno, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2021) DOI / 10.1007/s12094-020-02532-2 Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial Sierra-Rodero, Belen; Cruz-Bermudez, Alberto; Nadal, Ernest; Garitaonaindia, Yago; Insa, Amelia; Mosquera, Joaquin; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manu JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021) DOI / 10.1136/jitc-2021-002804
Mentions   0   Wikipedia   0   News   0   Policy
Review Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic Vilarino, N.; Bruna, J.; Bosch-Barrera, J.; Valiente, M.; Nadal, E. CANCER TREATMENT REVIEWS 0305-7372 (2020) DOI / 10.1016/j.ctrv.2020.102067
Mentions   0   Wikipedia   0   News   0   Policy
Article Malignant pleural mesothelioma: Treatment patterns and outcomes from the Spanish Lung Cancer Group Remon, J.; Nadal, E.; Domine, M.; Ruffinelli, J.; Garcia, Y.; Pardo, J. C.; Lopez, R.; Cilleruelo, A.; Garcia-Campelo, R.; Martin, P.; Juan, O.; Gonzalez-Larriba, J. L.; Provencio, M.; Olmedo, E.; Ponce, S.; Cumplido, D.; Barenys, C.; Majem, M.; Massutti, LUNG CANCER 0169-5002 (2020) DOI / 10.1016/j.lungcan.2020.06.034
Mentions   0   Wikipedia   0   News   0   Policy
Article Safety evaluation of nivolumab added concurrently to radiotherapy in a standard first line chemo-radiotherapy regimen in stage III non-small cell lung cancer-The ETOP NICOLAS trial Peters, S.; Felip, E.; Dafni, U.; Belka, C.; Guckenberger, M.; Irigoyen, A.; Nadal, E.; Becker, A.; Vees, H.; Pless, M.; Martinez-Marti, A.; Tufman, A.; Lambrecht, M.; Andratschke, N.; Piguet, A. C.; Kassapian, M.; Roschitzki-Voser, H.; Rabaglio-Poretti, M LUNG CANCER 0169-5002 (2019) DOI / 10.1016/j.lungcan.2019.05.001
Mentions   0   Wikipedia   1   News   0   Policy
Article Efficacy of CDK4/6 inhibitors in preclinical models of malignant pleural mesothelioma Aliagas, Elisabet; Alay, Ania; Martinez-Iniesta, Maria; Hernandez-Madrigal, Miguel; Cordero, David; Gausachs, Mireia; Pros, Eva; Saigi, Maria; Busacca, Sara; Sharkley, Annabel J.; Dawson, Alan; Palmero, Ramon; Ruffinelli, Jose C.; Padrones, Susana; Aso, Sa BRITISH JOURNAL OF CANCER 0007-0920 (2021) DOI / 10.1038/s41416-021-01547-y Green submitted
Mentions   0   Wikipedia   2   News   0   Policy
Article Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platfo Peters, Solange; Felip, Enriqueta; Dafni, Urania; Tufman, Amanda; Guckenberger, Matthias; Alvarez, Ruth; Nadal, Ernest; Becker, Annemarie; Vees, Hansjorg; Pless, Miklos; Martinez-Marti, Alex; Lambrecht, Maarten; Andratschke, Nicolaus; Tsourti, Zoi; Piguet, JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2021) DOI / 10.1016/j.jtho.2020.10.129 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC) Martinez-Marti, A.; Felip, E.; Matito, J.; Mereu, E.; Navarro, A.; Cedres, S.; Pardo, N.; Martinez de Castro, A.; Remon, J.; Miquel, J. M.; Guillaumet-Adkins, A.; Nadal, E.; Rodriguez-Esteban, G.; Arques, O.; Fasani, R.; Nuciforo, P.; Heyn, H.; Villanueva, ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdx396 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Seroprevalence and immunological memory against SARS-CoV-2 in lung cancer patients: the SOLID study Provencio, Mariano; Rodriguez-Abreu, Delvys; Ortega, Ana L.; Serrano, Gloria; Aguado, Carlos; Franco, Fernando; Gutierrez, Vanesa; Lopez Vivanco, Guillermo; Guirado, Maria; Benitez, Gretel; Estival, Anna; Calvo, Virginia; Jimenez, Beatriz; Arasanz, Hugo; C TRANSLATIONAL LUNG CANCER RESEARCH 2218-6751 (2021) DOI / 10.21037/tlcr-21-504 Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article Genome-wide profiling of non-smoking-related lung cancer cells reveals common RB1 rearrangements associated with histopathologic transformation in EGFR-mutant tumors Pros, E.; Saigi, M.; Alameda, D.; Gomez-Mariano, G.; Martinez-Delgado, B.; Alburquerque-Bejar, J. J.; Carretero, J.; Tonda, R.; Esteve-Codina, A.; Catala, I; Palmero, R.; Jove, M.; Lazaro, C.; Patino-Garcia, A.; Gil-Bazo, I; Verdura, S.; Teule, A.; Torres- ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2019.09.001 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article MET-Oncogenic and JAK2-Inactivating Alterations Are Independent Factors That Affect Regulation of PD-L1 Expression in Lung Cancer Saigi, Maria; Alburquerque-Bejar, Juan J.; Mc Leer-Florin, Anne; Pereira, Carolina; Pros, Eva; Romero, Octavio A.; Baixeras, Nuria; Esteve-Codina, Anna; Nadal, Ernest; Brambilla, Elisabeth; Sanchez-Cespedes, Montse CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0267 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial Popat, S.; Curioni-Fontecedro, A.; Dafni, U.; Shah, R.; O'Brien, M.; Pope, A.; Fisher, P.; Spicer, J.; Roy, A.; Gilligan, D.; Gautschi, O.; Nadal, E.; Janthur, W. D.; Castro, R. Lopez; Campelo, R. Garcia; Rusakiewicz, S.; Letovanec, I; Polydoropoulou, V; R ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.09.009
Mentions   0   Wikipedia   0   News   0   Policy
Article Integrative transcriptome analysis of malignant pleural mesothelioma reveals a clinically relevant immune-based classification Alay, Ania; Cordero, David; Hijazo-Pechero, Sara; Aliagas, Elisabet; Lopez-Doriga, Adriana; Marin, Raul; Palmero, Ramon; Llatjos, Roger; Escobar, Ignacio; Ramos, Ricard; Padrones, Susana; Moreno, Victor; Nadal, Ernest; Sole, Xavier JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021) DOI / 10.1136/jitc-2020-001601 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Gene Expression Profiling as a Potential Tool for Precision Oncology in Non-Small Cell Lung Cancer Hijazo-Pechero, Sara; Alay, Ania; Marin, Raul; Vilarino, Noelia; Munoz-Pinedo, Cristina; Villanueva, Alberto; Santamaria, David; Nadal, Ernest; Sole, Xavier CANCERS (2021) DOI / 10.3390/cancers13194734 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Article Genetic and cellular sensitivity of Caenorhabditis elegans to the chemotherapeutic agent cisplatin Javier Garcia-Rodriguez, Francisco; Martinez-Fernandez, Carmen; Brena, David; Kukhtar, Dmytro; Serrat, Xenia; Nadal, Ernest; Boxem, Mike; Honnen, Sebastian; Miranda-Vizuete, Antonio; Villanueva, Alberto; Ceron, Julian DISEASE MODELS & MECHANISMS 1754-8403 (2018) DOI / 10.1242/dmm.033506 Green published, Green submitted, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Letter Incidence, predictors and prognostic significance of thromboembolic disease in patients with advanced ALK-rearranged non-small cell lung cancer Zugazagoitia, Jon; Biosca, Mercedes; Oliveira, Julio; Eugenia Olmedo, Maria; Domine, Manuel; Nadal, Ernest; Carlos Ruffinelli, Jose; Munoz, Nerea; Maria Luna, Ana; Hernandez, Berta; Martinez, Maite; Gallego, Iria; Martinez de Castro, Eva; Font, Carme; Calv EUROPEAN RESPIRATORY JOURNAL 0903-1936 (2018) DOI / 10.1183/13993003.02431-2017 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Inhibitor of Differentiation-1 Sustains Mutant KRAS-Driven Progression, Maintenance, and Metastasis of Lung Adenocarcinoma via Regulation of a FOSL1 Network Roman, Marta; Lopez, Ines; Guruceaga, Elisabeth; Baraibar, Iosune; Ecay, Margarita; Collantes, Maria; Nadal, Ernest; Vallejo, Adrian; Cadenas, Silvia; Echavarri-de Miguel, Marta; Jang, Jae Hwi; San Martin-Uriz, Patxi; Castro-Labrador, Laura; Vilas-Zornoza, CANCER RESEARCH 0008-5472 (2019) DOI / 10.1158/0008-5472.can-18-1479 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinoma Nokin, Marie-Julie; Darbo, Elodie; Travert, Camille; Drogat, Benjamin; Lacouture, Aurelie; Jose, Sonia San; Cabrera, Nuria; Turcq, Beatrice; Prouzet-Mauleon, Valerie; Falcone, Mattia; Villanueva, Alberto; Wang, Haiyun; Herfs, Michael; Mosteiro, Miguel; Jan JCI INSIGHT (2020) DOI / 10.1172/jci.insight.137869 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Blood First Assay Screening Trial (BFAST) in Treatment-Naive Advanced or Metastatic NSCLC : Initial Results of the Phase 2 ALK-Positive Cohort Dziadziuszko, Rafal; Mok, Tony; Peters, Solange; Han, Ji-Youn; Alatorre-Alexander, Jorge; Leighl, Natasha; Sriuranpong, Virote; Perol, Maurice; de Castro Junior, Gilberto; Nadal, Ernest; de Marinis, Filippo; Frontera, Osvaldo Aren; Tan, Daniel S. W.; Lee, JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2021) DOI / 10.1016/j.jtho.2021.07.008 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Mutations in the Antioxidant KEAP1/NRF2 Pathway Define an Aggressive Subset of NSCLC Resistant to Conventional Treatments Nadal, Ernest; Palmero, Ramon; Munoz-Pinedo, Cristina JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2019) DOI / 10.1016/j.jtho.2019.08.005 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer Bosch-Barrera, Joaquim; Verdura, Sara; Carlos Ruffinelli, Jose; Carcereny, Enric; Sais, Elia; Cuyas, Elisabet; Palmero, Ramon; Lopez-Bonet, Eugeni; Hernandez-Martinez, Alejandro; Oliveras, Gloria; Buxo, Maria; Izquierdo, Angel; Moran, Teresa; Nadal, Ernest CANCERS (2021) DOI / 10.3390/cancers13164168 Green published, Gold
Mentions   0   Wikipedia   1   News   0   Policy
Editorial Material VP3-2021: A randomized phase II study of second-line osimertinib (Osi) and bevacizumab (Bev) versus Osi in advanced non-small-cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) and T790M mutations (mt): Results from the ETOP BOOSTER tria Soo, R.; Han, J-Y; Dimopoulou, G.; Cho, B. C.; Yeo, C. M.; Nadal, E.; Carcereny, E.; De Castro, J.; Sala, M. A.; Bernabe, R.; Coate, L.; Provencio, M.; Campelo, R. Garcia; Cuffe, S.; Hashemi, S.; Fruh, M.; Ruepp, B.; Roschitzki-Voser, H.; Stahel, R.; Peter ANNALS OF ONCOLOGY (2021) DOI / 10.1016/j.annonc.2021.04.010
Mentions   0   Wikipedia   2   News   0   Policy
Article Thyroid dysfunction induced by nivolumab: searching for disease patterns and outcomes Peiro, Inmaculada; Palmero, Ramon; Iglesias, Pedro; Jose Diez, Juan; Simo-Servat, Andreu; Antonio Marin, Juan; Jimenez, Laura; Domingo-Domenech, Eva; Mancho-Fora, Nuria; Nadal, Ernest; Villabona, Carlos ENDOCRINE 1355-008X (2019) DOI / 10.1007/s12020-019-01871-7
Mentions   0   Wikipedia   0   News   0   Policy
Article Geriatric assessment may help decision-making in elderly patients with inoperable, locally advanced non-small-cell lung cancer Antonio, Maite; Saldana, Juana; Linares, Jennifer; Ruffinelli, Jose C.; Palmero, Ramon; Navarro, Arturo; Dolores Arnaiz, Maria; Brao, Isabel; Aso, Samantha; Padrones, Susana; Navarro, Valenti; Gonzalez-Barboteo, Jesus; Maria Borras, Josep; Cardenal, Felipe BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/bjc.2017.455 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer Lopez-Plana, Anna; Fernandez-Nogueira, Patricia; Munoz-Guardiola, Pau; Sole-Sanchez, Sonia; Megias-Roda, Elisabet; Perez-Montoyo, Hector; Jauregui, Patricia; Yeste-Velasco, Marc; Gomez-Ferreria, Mariana; Erazo, Tatiana; Ametller, Elisabet; Recalde-Percaz, INTERNATIONAL JOURNAL OF CANCER 0020-7136 (2020) DOI / 10.1002/ijc.32865
Mentions   0   Wikipedia   0   News   0   Policy
Article Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy Bergamino, Milana; Rullan, Antonio J.; Saigi, Maria; Peiro, Inmaculada; Montanya, Eduard; Palmero, Ramon; Carlos Ruffinelli, Jose; Navarro, Arturo; Dolores Arnaiz, Maria; Brao, Isabel; Aso, Samantha; Padrones, Susana; Cardenal, Felipe; Nadal, Ernest BMC CANCER (2019) DOI / 10.1186/s12885-019-5370-5 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition Pereira, Carolina; Gimenez-Xavier, Pol; Pros, Eva; Pajares, Maria J.; Moro, Massimo; Gomez, Antonio; Navarro, Alejandro; Condom, Enric; Moran, Sebastian; Gomez-Lopez, Gonzalo; Grana, Osvaldo; Rubio-Camarillo, Miriam; Martinez-Marti, Alex; Yokota, Jun; Carr CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-16-1946
Mentions   0   Wikipedia   0   News   0   Policy
Article Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation Nadal, Ernest; Heeke, Simon; Benzaquen, Jonathan; Vilarino, Noelia; Navarro, Arturo; Azuara, Daniel; Varela, Mar; Otto, Josiane; Baixeras, Nuria; Shahbazian, David; Puchois, Pascal; Church, Sarah E.; Smith, Thomas H.; Lanteri, Elisabeth; Ilie, Marius; Hofm JCO PRECISION ONCOLOGY (2020) DOI / 10.1200/po.20.00174
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery Ramos, Ricard; Macia, Ivan; Navarro-Martin, Arturo; Deniz, Carlos; Rivas, Francisco; Urena, Anna; Masuet-Aumatell, Cristina; Moreno, Camilo; Nadal, Ernest; Escobar, Ignacio BMC PULMONARY MEDICINE 1471-2466 (2021) DOI / 10.1186/s12890-021-01446-1 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Targeting Infrequent Driver Alterations in Non-Small Cell Lung Cancer Nokin, Marie-Julie; Ambrogio, Chiara; Nadal, Ernest; Santamaria, David TRENDS IN CANCER 2405-8025 (2021) DOI / 10.1016/j.trecan.2020.11.005
Mentions   0   Wikipedia   0   News   0   Policy
Article Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung Cancer Palmero, Ramon; Taus, Alvaro; Viteri, Santiago; Majem, Margarita; Carcereny, Enric; Garde-Noguera, Javier; Felip, Enriqueta; Nadal, Ernest; Malfettone, Andrea; Sampayo, Miguel; Riva, Francois; Nagy, Rebecca J.; Lanman, Richard B.; Faull, Iris; Dix, Daniel; JCO PRECISION ONCOLOGY (2021) DOI / 10.1200/po.20.00241
Mentions   0   Wikipedia   0   News   0   Policy
Article RELAY Subgroup Analyses by EGFR Ex19del and Ex21L858R Mutations for Ramucirumab Plus Erlotinib in Metastatic Non-Small Cell Lung Cancer Nakagawa, Kazuhiko; Nadal, Ernest; Garon, Edward B.; Nishio, Makoto; Seto, Takashi; Yamamoto, Nobuyuki; Park, Keunchil; Shih, Jin-Yuan; Paz-Ares, Luis; Frimodt-Moller, Bente; Zimmermann, Annamaria H.; Wijayawardana, Sameera; Visseren-Grul, Carla; Reck, Mar CLINICAL CANCER RESEARCH 1078-0432 (2021) DOI / 10.1158/1078-0432.ccr-21-0273 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Identification of ALK, ROS1, and RET Fusions by a Multiplexed mRNA-Based Assay in Formalin-Fixed, Paraffin-Embedded Samples from Advanced Non-Small-Cell Lung Cancer Patients Reguart, Noemi; Teixido, Cristina; Gimenez-Capitan, Ana; Pare, Laia; Galvan, Patricia; Viteri, Santiago; Rodriguez, Sonia; Peg, Vicente; Aldeguer, Erika; Vinolas, Nuria; Remon, Jordi; Karachaliou, Niki; Conde, Esther; Lopez-Rios, Fernando; Nadal, Ernest; M CLINICAL CHEMISTRY 0009-9147 (2017) DOI / 10.1373/clinchem.2016.265314 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical and economic impact of current ALK rearrangement testing in Spain compared with a hypothetical no-testing scenario Nadal, Ernest; Bautista, Dolores; Cabezon-Gutierrez, Luis; Ortega, Ana Laura; Torres, Hector; Carcedo, David; Ruiz de Alda, Lucia; Francisco Garcia, J.; Vieitez, Paula; Rojo, Federico BMC CANCER (2021) DOI / 10.1186/s12885-021-08407-1 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome Mezquita, Laura; Jove, Maria; Nadal, Ernest; Kfoury, Maria; Moran, Teresa; Ricordel, Charles; Dhooge, Marion; Tlemsani, Camille; Lena, Herve; Teule, Alex; Alvarez, Jose-Valero; Raimbourg, Judith; Hiret, Sandrine; Lacroix, Ludovic; Menendez, Mireia; Saldana JOURNAL OF THORACIC ONCOLOGY 1556-0864 (2020) DOI / 10.1016/j.jtho.2020.03.005
Mentions   0   Wikipedia   0   News   0   Policy
Article RELAY, Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients with Untreated, Epidermal Growth Factor Receptor Mutation-Positive, Metastatic Non-Small-Cell Lung Cancer: Safety Profile and Manageability Nadal, Ernest; Horinouchi, Hidehito; Shih, Jin-Yuan; Nakagawa, Kazuhiko; Reck, Martin; Garon, Edward B.; Wei, Yu-Feng; Kollmeier, Jens; Frimodt-Moller, Bente; Barrett, Emily; Lipkovich, Olga; Visseren-Grul, Carla; Novello, Silvia DRUG SAFETY 0114-5916 (2021) DOI / 10.1007/s40264-021-01127-2 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Review Multidisciplinary expert opinion on the treatment consensus for patients with EGFR mutated NSCLC with brain metastases Ponce, Santiago; Bruna, Jordi; Juan, Oscar; Lopez, Rafael; Navarro, Alejandro; Laura Ortega, Ana; Puente, Javier; Verger, Eugenia; Bartolome, Adela; Nadal, Ernest CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY 1040-8428 (2019) DOI / 10.1016/j.critrevonc.2019.03.017
Mentions   0   Wikipedia   0   News   0   Policy
Article Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Forman-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer Evrard, Solene M.; Taranchon-Clermont, Estelle; Rouquette, Isabelle; Murray, Samuel; Dintner, Sebastian; Nam-Apostolopoulos, Yun-Chung; Bellosillo, Beatriz; Varela-Rodriguez, Mar; Nadal, Ernest; Wiedorn, Klaus H.; Melchior, Linea; Andrew, Emma; Jones, Mary JOURNAL OF MOLECULAR DIAGNOSTICS 1525-1578 (2019) DOI / 10.1016/j.jmoldx.2019.06.010 Green published, Gold other, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non-Small-Cell Lung Cancer Garon, Edward B.; Reck, Martin; Paz-Ares, Luis; Ponce, Santiago; Corral Jaime, Jesus; Juan, Oscar; Nadal, Ernest; Lee, Pablo; Dalal, Rita; Liu, Jingyi; He, Shuang; Treat, Joseph; Nakagawa, Kazuhiko CLINICAL LUNG CANCER 1525-7304 (2017) DOI / 10.1016/j.cllc.2016.05.023
Mentions   0   Wikipedia   0   News   0   Policy
Article Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics Mezquita, Laura; Preeshagul, Isabel; Auclin, Edouard; Saravia, Diana; Hendriks, Lizza; Rizvi, Hira; Park, Wungki; Nadal, Ernest; Martin-Romano, Patricia; Ruffinelli, Jose C.; Ponce, Santiago; Audigier-Valette, Clarisse; Carnio, Simona; Blanc-Durand, Felix; EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.03.011 Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR-Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results Reck, Martin; Garon, Edward B.; Paz-Ares, Luis; Ponce, Santiago; Corral Jaime, Jesus; Juan, Oscar; Nadal, Ernest; Kiura, Katsuyuki; Widau, Ryan C.; He, Shuang; Dalal, Rita; Lee, Pablo; Nakagawa, Kazuhiko CLINICAL LUNG CANCER 1525-7304 (2018) DOI / 10.1016/j.cllc.2017.11.003 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article INSIGHT 2: a Phase II study of tepotinib plus osimertinib in MET-amplified NSCLC and first-line osimertinib resistance Smit, Egbert F.; Dooms, Christophe; Raskin, Jo; Nadal, Ernest; Tho, Lye M.; Le, Xiuning; Mazieres, Julien; Hin, How S.; Morise, Masahire; Zhu, Viola W.; Tan, Daniel; Holmberg, Kristina H.; Ellers-Lenz, Barbara; Adrian, Svenja; Brutlach, Sabine; Schumacher, FUTURE ONCOLOGY (2021) DOI / 10.2217/fon-2021-1406
Mentions   0   Wikipedia   0   News   0   Policy
Article Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy Zhang, Xuanye; Tian, Dan; Chen, Yue; Chen, Chen; He, Li-Na; Zhou, Yixin; Li, Haifeng; Lin, Zuan; Chen, Tao; Wang, Yuhong; Russo, Alessandro; Nadal, Ernest; Passiglia, Francesco; Soo, Ross Andrew; Watanabe, Satoshi; Moran, Teresa; Oh, In-Jae; Fu, Sha; Hong, TRANSLATIONAL LUNG CANCER RESEARCH 2218-6751 (2021) DOI / 10.21037/tlcr-21-455 Gold, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Genetic screening and molecular characterization of MET alterations in non-small cell lung cancer Saigi, M.; McLeer-Florin, A.; Pros, E.; Nadal, E.; Brambilla, E.; Sanchez-Cespedes, M. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1799-7
Mentions   0   Wikipedia   0   News   0   Policy
Article A Randomized Phase III Study of Abemaciclib Versus Erlotinib in Patients with Stage IV Non-small Cell Lung Cancer With a Detectable KRAS Mutation Who Failed Prior Platinum-Based Therapy: JUNIPER Goldman, Jonathan W.; Mazieres, Julien; Barlesi, Fabrice; Dragnev, Konstantin H.; Koczywas, Marianna; Goskel, Tuncay; Cortot, Alexis B.; Girard, Nicolas; Wesseler, Claas; Bischoff, Helge; Nadal, Ernest; Park, Keunchil; Lu, Shun; Taus, Alvaro; Cobo, Manuel; FRONTIERS IN ONCOLOGY 2234-943X (2020) DOI / 10.3389/fonc.2020.578756 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancer Gasa, L.; Sanchez-Botet, A.; Quandt, E.; Hernandez-Ortega, S.; Jimenez, J.; Carrasco-Garcia, M. A.; Simonetti, S.; Kron, S. J.; Ribeiro, M. P.; Nadal, E.; Villanueva, A.; Clotet, J. SCIENTIFIC REPORTS 2045-2322 (2017) DOI / 10.1038/s41598-017-10770-8 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Review Immunotherapy with checkpoint inhibitors in non-small cell lung cancer: insights from long-term survivors Nadal, Ernest; Massuti, Bartomeu; Domine, Manuel; Garcia-Campelo, Rosario; Cobo, Manuel; Felip, Enriqueta CANCER IMMUNOLOGY IMMUNOTHERAPY 0340-7004 (2019) DOI / 10.1007/s00262-019-02310-2
Mentions   0   Wikipedia   0   News   0   Policy
Review The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer Akhoundova, D.; Mosquera Martinez, J.; Musmann, L. E.; Britschgi, C.; Rutsche, C.; Rechsteiner, M.; Nadal, E.; Garcia Campelo, M. R.; Curioni-Fontecedro, A. JOURNAL OF CLINICAL MEDICINE (2020) DOI / 10.3390/jcm9113674 Gold other, Green published, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Impact of baseline steroids on efficacy of programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) blockade in patients with advanced non-small cell lung cancer Jove, Maria; Vilarino, Noelia; Nadal, Ernest TRANSLATIONAL LUNG CANCER RESEARCH 2218-6751 (2019) DOI / 10.21037/tlcr.2019.06.06 Gold other, Green published

Más rankings

InfluScience